Malaysia Drug Registration is the process by which pharmaceutical products are evaluated and approved by the National Pharmaceutical Regulatory Agency (NPRA) to ensure their safety, efficacy, and quality. This involves a thorough review of documentation, clinical data, and compliance with regulatory standards before a product can be marketed in Malaysia.
